Navigation Links
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Date:8/25/2008

Appoints Stephen Ross Senior Vice President of Commercial Operations and James Briggs Senior Vice President of Human Resources

CLINTON, N.J., Aug. 25 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today the addition of two key executives. Stephen A. Ross was appointed Senior Vice President of Commercial Operations and James Briggs was named Senior Vice President for Human Relations.

Daniel Tasse, President & CEO of Ikaria, remarked, "Steve and James add significant skills and experience to Ikaria as we continue to build our organization to achieve the leadership position in Critical Care. Steve infuses Ikaria with extensive experience in driving the marketing and sales of pharmaceutical products, while James brings with him a strong track record in creating operational efficiencies and driving employee development. We are confident that both will provide vital contributions to Ikaria as we advance our development pipeline and work to increase commercial opportunities for INOmax(R). We are pleased to welcome Steve and James to the Ikaria team and look forward to working with them as we expand our organization to meet the needs of our growing business."

Mr. Ross previously served as Senior Vice President, Sales and Marketing at Cytogen, a specialty pharmaceutical company. At Cytogen, he was responsible for sales and marketing of Cytogen's four-product oncology portfolio. Prior to Cytogen, he spent fifteen years at GlaxoSmithKline where he held several positions, including Vice President, Specialist Business Units, GSK UK and General Manager of GSK Ireland. During his tenure at GSK, he managed sales and marketing for hospital and specialty products. Mr. Ross holds an MBA from The Wharton School, University of Pennsylvania and a BA in economics from Brigham Young University.

Mr. Briggs was previously Director, Human Resources of Avaya Global Services, a global IP Telephony Products and Services Company, where he led a human resources team that served more than 5,000 employees globally. Prior to joining Avaya, he served as Vice President, Human Resources at GE's Access Distribution, a global IT distributor with more than 600 employees. Before GE, he held human resources positions at Unilever and The Pepsi Bottling Company. Mr. Briggs holds an MA in industrial relations and a BA in communications, both from the University of Illinois.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceutical and biological products and drug/device combinations for the critically ill in the hospital and ICU setting. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to the ongoing clinical development as well as the marketing and selling of its INOmax product, Ikaria is engaged in a number of Phase 2 trials with Covox(R) (carbon monoxide) for inhalation and Phase 1 trials with hydrogen sulfide (H2S) for various critical care indications. Ikaria has a staff of approximately 400 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit http://www.ikaria.com.
CONTACTS

Matthew Bennett

Ikaria

(908) 238-6673

matthew.bennett@ikaria.com

Jason Rando

The Ruth Group

646-536-7025

jrando@theruthgroup.com


'/>"/>
SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Milestone Biosciences, LLC Further Strengthens Executive Management Team
2. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
3. Cell Biosciences Strengthens Management Team
4. DuPont Strengthens Commitment to Responsible Science with New Biotech Advisory Panel Members
5. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
6. Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement
7. GeoVax Further Strengthens Management Team
8. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
9. SpectraScience Strengthens Leadership Team With Four Key Hires
10. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):